Pronase Treatment Interfering with T Cell Crossmatch

被引：1
|
作者：
Backer, M. [1 ]
Steward, K. [1 ]
Wegner, W. [1 ]
Balgansuren, G. [1 ]
Chen, D. -F. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Pathol & Clin Labs, Durham, NC 27706 USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-01557
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2403
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [21] THE EFFECT OF PRONASE ON LYMPHOCYTE SURFACE MARKERS AND IMPLICATIONS FOR FLOW CYTOMETRIC CROSSMATCH.
    Lazar-Molnar, Eszter
    Spruit, Laura
    Pole, Ann
    Williams, Kevin
    Taylor, Michelle R.
    Delgado, Julio C.
    HUMAN IMMUNOLOGY, 2015, 76 : 131 - 131
  • [22] AGGREGATED IGG CONTROL FOR PRONASE FC RECEPTOR (FCR) REMOVAL IN FLOW CROSSMATCH
    Geier, Steven S.
    Lai, Phi A.
    Lin, Justin
    Lai, Phoebe W.
    Rudic, Joseph L.
    Parekh, Hemant K.
    HUMAN IMMUNOLOGY, 2014, 75 : 54 - 54
  • [23] USING PRONASE PRE-TREATMENT CDC-CROSSMATCH TO STUDY THE RITUXIMAB KINETICS IN KIDNEY TRANSPLANT CANDIDATES AND RECIPIENTS
    Gandolfini, Ilaria
    Zanelli, Paola
    Palmisano, Alessandra
    Benigno, Giuseppe Daniele
    Fiaccadori, Enrico
    Maggiore, Umberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2051 - 2051
  • [24] THE FIRST DOCUMENTED EVIDENCE OF DARATUMUMAB INTERFERING WITH FLOW CYTOMETRIC CROSSMATCH
    Ho, S.
    Putnam, K.
    Peiter, C.
    Herczyk, W.
    Gerlach, J.
    HUMAN IMMUNOLOGY, 2021, 82 : 74 - 74
  • [25] INTERFERING FACTORS INTERFERE WITH VIRTUAL CROSSMATCH (vXM) INTERPRETATION.
    McRacken, Tracy T.
    Keatley, Katherine
    Stephens, Monica
    Hogan, Kevin
    Spraggins, Cynthia
    Zannini, Alyssa
    Fortes, Weenafreda
    Phelps, Elaine
    Bray, Robert A.
    Gebel, Howard M.
    HUMAN IMMUNOLOGY, 2013, 74 : 70 - 70
  • [26] EVALUATION OF LUMINEX®-BASED CROSSMATCH (XM) VS T-CELL AND B-CELL FLOW CYTOMETRY CROSSMATCH (FCXM)
    Jayamohan, Yasodah
    Brailey, Paul
    Adams, Patrick
    Nordman, David
    Susskind, Brian
    HUMAN IMMUNOLOGY, 2008, 69 : S16 - S16
  • [27] THE CHROMIUM RELEASE T-CELL CROSSMATCH (CRCM) - IS IT OF VALUE
    MARGOLIUS, LP
    MEYERS, AM
    BOTHA, JR
    SEGGIE, J
    THOMSON, PD
    SMIT, JA
    NORTMAN, P
    MYBURGH, JA
    KIDNEY INTERNATIONAL, 1989, 35 (03) : 909 - 909
  • [28] Impact of rituximab on the T-cell flow cytometric crossmatch
    Doss, Sam Arul
    Mittal, Siddharth
    Daniel, Dolly
    TRANSPLANT IMMUNOLOGY, 2021, 64
  • [29] Positive donor T-cell crossmatch: A revisit in the nineties
    Wade, JA
    Cole, EH
    Zaltzman, JS
    Pellett, F
    Chan, L
    Lampty, M
    Cardella, CJ
    HUMAN IMMUNOLOGY, 1997, 55 : 77 - 77
  • [30] CLINICAL-SIGNIFICANCE OF A BLOOD-VESSEL CROSSMATCH IN PATIENTS WITH A POSITIVE CURRENT T-CELL CROSSMATCH
    CERILLI, J
    BIAS, W
    GERSTENBERGER, C
    CLARKE, J
    BRASILE, L
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 758 - 759
12345